ning treatment and prevention trials with amyloid-lowering agents in AD. O1-03-03 CEREBRAL AMYLOID ANGIOPATHY IN ALZHEIMER’S DISEASE IS ASSOCIATEDWITH INCREASED BLOOD-BRAIN BARRIER PERMEABILITY: A QUANTITATIVE [11C]PIB-PET STUDY